Medical Marijuana Use in HIV+ Patients Prospective Cohort Study

The investigators are interested in understanding personal factors such as medical conditions and mental health, as well as social and economic factors, that influence marijuana (and other substance) use in HIV-positive patients.

Several alternative hypotheses will be evaluated in the proposed project:

1. healthier patients may self-select marijuana use; 2. marijuana use may be associated with consequences that create barriers to seeking healthcare; 3. marijuana use may have medicinal value that reduces the need for such care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Positive Behavior Blood-Borne Infections Communicable Diseases Genital Diseases HIV Infections HIV Seropositivity Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections Marijuana Smoking Marijuana Use RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Smoking Smoking, Non-Tobacco Products Urogenital Diseases Virus Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Wayne State University (HIV clinic, Tolan Park Medical Buiding)

Detroit, Michigan, 48201, United States

About this study

The study will involve a total of 5 interviews with clinical research staff members, the total involvement will be for about 1 year.

The first interview will establish a baseline of current behaviors and health status; this will take about 3-4 hours. This interview will take place at the Tolan Park Medical Building, located at 3901 Chrysler Service Dr. The remaining 4 interviews - which will be shorter in length - will be conducted about 3, 6, 9, and 12 months after the baseline interview; each follow-up interview will take about 2 hours.The purpose of the 4 remaining interviews is to assess changes in behaviors and health status over time.

We will collect urine samples at each of the 5 interview sessions to assess health and illicit drug use.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participants will be patients in the HIV clinic.
Participants will have HIV.
Participants will sign a single consent form.
Participants will be marijuana users.

Exclusion criteria

Participants who test negative for marijuana will be excluded.
Volunteers who exhibit signs of drug intoxication or cognitive/mental impairment during the consent process will be excluded.

Sponsors and collaborators

Lead sponsor

Wayne State University

Other

Collaborators

National Institute on Drug Abuse (NIDA)

Registry information

Official study title

Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients Prospective Cohort Study

Acronym: MMC-1

Important dates

Study start: 2012
Primary completion: 2017
Study completion: 2017
First posted: Feb 22, 2012
Registry last updated: Apr 5, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed